Vitamin D Receptor antibody (AA 274-299)
Quick Overview for Vitamin D Receptor antibody (AA 274-299) (ABIN3029599)
Target
See all Vitamin D Receptor (VDR) AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 274-299
-
Purpose
- VDR Antibody
-
Purification
- Antigen affinity
-
Immunogen
- A portion of amino acids 274-299 from the human protein was used as the immunogen for this VDR antibody.
-
Isotype
- Ig Fraction
-
-
-
-
Application Notes
- Titration of the VDR antibody may be required due to differences in protocols and secondary/substrate sensitivity.
-
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Buffer
- In 1X PBS, pH 7.4, with 0.09 % sodium azide
-
Preservative
- Sodium azide
-
Precaution of Use
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Storage
- -20 °C
-
Storage Comment
- Aliquot the VDR antibody and store frozen at -20oC or colder. Avoid repeated freeze-thaw cycles.
-
-
- Vitamin D Receptor (VDR)
-
Alternative Name
- VDR
-
Target Type
- Chemical
-
Background
- This gene encodes the nuclear hormone receptor for vitamin D3. This receptor also functions as a receptor for the secondary bile acid lithocholic acid. The receptor belongs to the family of trans-acting transcriptional regulatory factors and shows sequence similarity to the steroid and thyroid hormone receptors. Downstream targets of this nuclear hormone receptor are principally involved in mineral metabolism though the receptor regulates a variety of other metabolic pathways, such as those involved in the immune response and cancer. Mutations in this gene are associated with type II vitamin D-resistant rickets. A single nucleotide polymorphism in the initiation codon results in an alternate translation start site three codons downstream. Alternative splicing results in multiple transcript variants encoding the same protein.
-
UniProt
- P11473
-
Pathways
- Nuclear Receptor Transcription Pathway, Steroid Hormone Mediated Signaling Pathway
Target
-